Bivalirudin versus unfractionated heparin during peripheral vascular interventions
Catheterization and Cardiovascular Interventions2016Vol. 89(3), pp. 408–413
Citations Over TimeTop 16% of 2016 papers
Daniel Ortíz, Maharaj Singh, Arshad Jahangir, Suhail Allaqaband, Jayant Khitha, Tanvir Bajwa, Mark W. Mewissen
Abstract
Patients who received bivalirudin had lower rates of access site hematoma, shorter length of stay, and improved discharge status compared with unfractionated heparin during hospitalization for peripheral vascular intervention. Randomized comparisons of these agents are needed to confirm these findings. © 2016 Wiley Periodicals, Inc.
Related Papers
- Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature.(2004)
- → Combined Use of Bivalirudin and Radial Access in Acute Coronary Syndromes Is Not Superior to the Use of Either One Separately(2016)24 cited
- → Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST‐segment elevation myocardial infarctions: Comparison of outcomes in a “real‐world” setting(2017)5 cited
- → Heparin, bivalirudin, or the best of both for STEMI interventions(2019)3 cited
- Bivalirudin in the cardiac cath lab: streamlining the percutaneous coronary intervention experience.(2004)